FBRX RSI Chart
Last 7 days
-20%
Last 30 days
-18.9%
Last 90 days
-13.0%
Trailing 12 Months
-39.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2020 | 0 | 0 | 0 | 0 |
2019 | 13.5M | 9.0M | 4.5M | 36.0K |
2018 | 438.0K | 666.0K | 18.7M | 18.0M |
2017 | 76.8K | 104.5K | 132.3K | 160.0K |
2016 | 106.8K | 87.5K | 68.3K | 49.0K |
2015 | 0 | 0 | 0 | 126.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 01, 2024 | wagner paul a. | sold (taxes) | -1,735 | 0.7075 | -2,453 | see remarks |
Apr 01, 2024 | wagner paul a. | acquired | - | - | 31,250 | see remarks |
Apr 01, 2024 | riley antony a | sold (taxes) | -2,366 | 0.7075 | -3,345 | chief financial officer |
Apr 01, 2024 | riley antony a | acquired | - | - | 9,375 | chief financial officer |
Jan 01, 2024 | chen hubert c | sold (taxes) | -2,525 | 0.8217 | -3,073 | see remarks |
Jan 01, 2024 | chen hubert c | acquired | - | - | 7,500 | see remarks |
Jan 01, 2024 | wagner paul a. | sold (taxes) | -3,376 | 0.8217 | -4,109 | see remarks |
Jan 01, 2024 | wagner paul a. | acquired | - | - | 31,250 | see remarks |
Jan 01, 2024 | riley antony a | sold (taxes) | -3,156 | 0.8217 | -3,841 | chief financial officer |
Jan 01, 2024 | riley antony a | acquired | - | - | 9,375 | chief financial officer |
Which funds bought or sold FBRX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | STATE STREET CORP | unchanged | - | -5,041 | 29,194 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | added | 227 | 12,693 | 19,774 | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | added | 0.16 | -2,579 | 14,463 | -% |
May 15, 2024 | FARALLON CAPITAL MANAGEMENT LLC | unchanged | - | -219,065 | 1,268,590 | 0.01% |
May 15, 2024 | Royal Bank of Canada | new | - | - | - | -% |
May 15, 2024 | BVF INC/IL | unchanged | - | -360,835 | 2,089,560 | 0.06% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | reduced | -0.24 | -5,210 | 28,450 | -% |
May 15, 2024 | PERCEPTIVE ADVISORS LLC | unchanged | - | -409,802 | 2,273,340 | 0.04% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | reduced | -27.93 | -4,937 | 7,743 | -% |
May 15, 2024 | TWO SIGMA ADVISERS, LP | unchanged | - | -3,112 | 17,259 | -% |
Unveiling Forte Biosciences, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Forte Biosciences, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Forte Biosciences, Inc. News
Income Statement (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 | 2017Q2 | 2017Q1 | 2016Q4 | 2016Q3 | 2016Q2 | 2016Q1 | 2015Q4 |
Revenue | -70.1% | 0.00 | 0.00 | 0.00 | 0.00 | 6.00 | 12.00 | 18.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
Operating Expenses | -81.1% | 2.00 | 11.00 | 1.00 | 1.00 | 17.00 | 19.00 | 17.00 | 15.00 | - | - | - | - | - | - | - | - | - | - |
S&GA Expenses | 140.7% | 1.00 | -1.65 | 0.00 | 0.00 | 4.00 | 3.00 | 4.00 | 3.00 | 2.00 | - | - | - | - | - | - | - | - | - |
R&D Expenses | -58.6% | 3.00 | 8.00 | 13.00 | 12.00 | 12.00 | 16.00 | 12.00 | 13.00 | 10.00 | 8.00 | 8.00 | 7.00 | 7.00 | 7.00 | 8.00 | 7.00 | 6.00 | - |
Interest Expenses | 129.4% | 1.00 | 0.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | - |
Income Taxes | - | - | - | - | - | - | 0.00 | 2.00 | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 100.0% | - | -10.58 | -18.73 | - | - | -19.41 | 1.00 | - | - | - | -9.95 | - | - | - | - | - | - | - |
Net Income | 80.6% | -2.05 | -10.58 | -0.69 | -0.63 | -1.18 | -19.60 | -0.38 | -16.09 | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -17.9% | 32.00 | 39.00 | 48.00 | 31.00 | 37.00 | 42.00 | 45.00 | 40.00 | 41.00 | 43.00 | 47.00 | 53.00 | 57.00 | 61.00 | 23.00 | 28.00 | 19.00 | 8.00 | 71.00 | 85.00 | 95.00 |
Current Assets | -17.8% | 32.00 | 38.00 | 47.00 | 31.00 | 36.00 | 42.00 | 45.00 | 39.00 | 40.00 | 43.00 | 47.00 | 52.00 | 56.00 | 60.00 | 22.00 | 28.00 | 15.00 | 8.00 | 60.00 | 73.00 | 82.00 |
Cash Equivalents | -17.9% | 30.00 | 37.00 | 46.00 | 20.00 | 36.00 | 41.00 | 44.00 | 39.00 | 40.00 | 42.00 | 46.00 | 51.00 | 55.00 | 59.00 | 20.00 | 28.00 | 4.00 | 7.00 | 8.00 | 8.00 | 31.00 |
Net PPE | -2.8% | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 4.00 | 4.00 | 4.00 |
Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.00 | 17.00 | 51.00 | 49.00 | 50.00 |
Current Liabilities | -9.1% | 3.00 | 4.00 | 7.00 | 6.00 | 4.00 | 3.00 | 2.00 | 2.00 | 1.00 | 2.00 | 4.00 | 3.00 | 2.00 | 2.00 | 2.00 | 3.00 | 13.00 | 2.00 | 42.00 | 17.00 | 16.00 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.00 | 24.00 |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.00 | 24.00 |
Shareholder's Equity | -18.8% | 29.00 | 35.00 | 40.00 | 25.00 | 33.00 | 39.00 | 43.00 | 38.00 | 40.00 | 42.00 | 44.00 | 50.00 | 55.00 | 59.00 | 20.00 | 25.00 | 2.00 | 11.00 | 20.00 | 36.00 | 45.00 |
Retained Earnings | -6.2% | -125 | -118 | -112 | -102 | -93.80 | -87.04 | -82.20 | -78.80 | -75.70 | -73.17 | -69.80 | -62.10 | -56.26 | -51.46 | -46.90 | -41.80 | -289 | -4.97 | -268 | -250 | -232 |
Additional Paid-In Capital | 0.5% | 155 | 154 | 153 | 128 | 127 | 126 | 125 | 117 | 116 | 115 | 113 | 112 | 111 | 110 | 67.00 | 67.00 | 292 | 0.00 | 289 | 286 | 278 |
Accumulated Depreciation | 100.0% | 0.00 | 0.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.00 | - | - | - |
Shares Outstanding | 0.2% | 36.00 | 36.00 | 36.00 | 21.00 | 21.00 | 21.00 | 21.00 | 15.00 | 15.00 | 15.00 | 14.00 | 14.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 20.00 | - | - | - | 18.00 | - | - | - | 396 | - | - | - | 72.00 | - | - | - | 223 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 25.7% | -6,667 | -8,969 | -9,037 | -5,496 | -5,204 | -2,893 | -1,940 | -1,377 | -1,975 | -3,582 | -5,127 | -3,938 | -4,030 | -3,803 | -7,739 | -4,016 | -2,865 | -653 | -553 | 16,117 | -17,682 |
Share Based Compensation | 3.2% | 805 | 780 | 772 | 855 | 877 | 860 | 906 | 1,194 | 1,055 | 1,238 | 1,473 | 1,008 | 495 | 555 | 375 | 24.00 | 2.00 | 31.00 | 2.00 | -1,997 | 2,000 |
Cashflow From Investing | 62.5% | -6.00 | -16.00 | 10,028 | - | - | - | - | - | - | - | - | - | - | - | -1.00 | -9,139 | 12,722 | -89.00 | -5,764 | -406 | 6,097 |
Cashflow From Financing | 89.3% | -8.00 | -75.00 | 24,777 | -24.00 | 6.00 | -55.00 | 7,440 | -110 | -34.00 | -39.00 | -3.00 | -29.00 | 27.00 | 42,393 | 166 | 24,063 | 45.00 | - | - | 3,086 | 1,770 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development (including $29 and $0 of related party transactions for the 3 months ending March 31, 2024 and 2023, respectively) | $ 4,353 | $ 4,787 |
General and administrative | 3,451 | 2,068 |
Total operating expenses | 7,804 | 6,855 |
Loss from operations | (7,804) | (6,855) |
Other income, net | 384 | 102 |
Net loss | $ (7,420) | $ (6,753) |
Net loss per share - basic | $ (0.16) | $ (0.32) |
Net loss per share - diluted | $ (0.16) | $ (0.32) |
Weighted average shares and pre-funded warrants outstanding, basic | 46,082,861 | 21,006,680 |
Weighted average shares and pre-funded warrants outstanding, diluted | 46,082,861 | 21,006,680 |
Comprehensive Loss: | ||
Net loss | $ (7,420) | $ (6,753) |
Unrealized loss on available-for-sale securities | (6) | |
Comprehensive loss | $ (7,426) | $ (6,753) |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 30,444 | $ 37,125 |
Prepaid expenses and other current assets | 1,058 | 1,202 |
Total current assets | 31,502 | 38,327 |
Property and equipment, net | 106 | 109 |
Other assets | 409 | 544 |
Total assets | 32,017 | 38,980 |
Current liabilities: | ||
Accounts payable | 1,685 | 1,424 |
Accrued liabilities | 1,647 | 2,242 |
Total current liabilities | 3,332 | 3,666 |
Commitments and contingencies (Note 6) | ||
Stockholders’ equity | ||
Common stock, $0.001 par value: 200,000,000 shares authorized as of March 31, 2024 (unaudited) and December 31, 2023; 36,394,882 and 36,335,105 shares issued and outstanding as of March 31, 2024 (unaudited) and December 31, 2023, respectively | 36 | 36 |
Additional paid-in capital | 154,591 | 153,794 |
Accumulated other comprehensive income (loss) | (2) | 4 |
Accumulated deficit | (125,940) | (118,520) |
Total stockholders’ equity | 28,685 | 35,314 |
Total liabilities and stockholders' equity | $ 32,017 | $ 38,980 |